Active Shortage

SANDOSTATIN

NOVARTIS PHARMACEUTICALS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of SANDOSTATIN in Canada?

Yes. SANDOSTATIN 50MCG has an active shortage reported to Health Canada (last updated October 1, 2024).

Why is SANDOSTATIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will SANDOSTATIN be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products · 1 same form & route

Affected strength50MCG

Report last updated2024-10-01

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

OCTREOTIDE INJECTION

STERIMAX INC

100MCG · DIN 02560240

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

SANDOSTATIN LAR

NOVARTIS PHARMACEUTICALS CANADA INC

30MG · DIN 02239325

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

OCTREOTIDE DEPOT

STERIMAX INC

10MG · DIN 02567776

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

00839191

Strength

50MCG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS INTRAVENOUS

Active Ingredient

OCTREOTIDE

Tier

Unrated

Last Updated

2024-10-01

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from NOVARTIS PHARMACEUTICALS CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

10MG · DIN 02339528

2.5MG · DIN 02369257

5MG · DIN 02339501

7.5MG · DIN 02450267

2MG · DIN 02425645

3MG · DIN 02425653